SALIVARY GLAND CANCER
Clinical trials for SALIVARY GLAND CANCER explained in plain language.
Never miss a new study
Get alerted when new SALIVARY GLAND CANCER trials appear
Sign up with your email to follow new studies for SALIVARY GLAND CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug combo shows promise against rare salivary cancer
Disease control CompletedThis study tested whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink or control advanced salivary gland cancer that has come back or spread. 64 adults with different types of salivary cancer took part. The main goal was to see how many patients' tumor…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Prostate cancer drug shows promise for rare salivary gland tumors
Disease control CompletedThis study tested a drug called darolutamide, usually used for prostate cancer, in 57 people with a rare type of salivary gland cancer that has a specific protein (androgen receptor). The goal was to see if the drug could shrink tumors or slow the cancer. Some participants also r…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: National Cancer Center Hospital East • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Gene-Tailored drugs show promise for rare salivary gland cancer
Disease control CompletedThis study looked at whether giving people with advanced salivary gland cancer a drug that matches their tumor's genetic makeup can help control the disease. 114 participants first had their tumor genes analyzed. If a targetable change was found, they got a matched drug; if not, …
Matched conditions: SALIVARY GLAND CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 14, 2026 12:05 UTC